Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

The Prion-like Protein Doppel (Dpl) Interacts with the Human Receptor for Activated C-Kinase 1 (RACK1) Protein

ALBERTO AZZALIN, IGOR DEL VECCHIO, LUCA FERRETTI and SERGIO COMINCINI
Anticancer Research November 2006, 26 (6B) 4539-4547;
ALBERTO AZZALIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IGOR DEL VECCHIO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LUCA FERRETTI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SERGIO COMINCINI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sergio.c{at}ipvgen.unipv.it
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Doppel (Dpl) is a homologue of the prion protein (PrPC). In contrast to PrPC, Dpl is dispensable for prion disease, but appears to have an essential function in male spermatogenesis. Recently, Dpl has been found to be aberrantly expressed in astrocytic and leukaemic tumor specimens, showing a peculiar cytosolic cellular localization. The aim of this study was to clarify some of the putative Dpl interacting proteins. Materials and Methods: A yeast two hybrid system was employed and the results were verified by co-immunoprecipitation using transfected cells. Results: Several potential Dpl-binding candidates were identified and, among them, the receptor for activated C-kinase (RACK1) protein was further investigated. RACK1 deletion mutants showed that some of its WD containing domains were directly involved in the binding with Dpl. Our data showed that Dpl interacts with RACK1 by means of its structured globular carboxyl-terminal region. Conclusion: This new Dpl interacting partner might suggest functional hypotheses about the role of this protein in an astrocytoma context where Dpl was found ectopically expressed.

  • Doppel
  • RACK1
  • protein interaction

Footnotes

  • Abbreviations: AD, activation domain; BD, binding domain; DMEM, Dulbecco's modified Eagle's medium; ONPG, 2-nitrophenyl β-D-galactopyranoside; PBS, phosphate-buffered saline; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; X-Gal, 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside; WD, tryptophan-aspartic acid; GPI, glucosyl-phosphatidylinositol; LRP, laminin receptor, GFAP, glial fibrillary acidic protein; Grb2, growth factor receptor-bound protein2.

  • Received August 3, 2006.
  • Accepted October 9, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 6B
November-December 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Prion-like Protein Doppel (Dpl) Interacts with the Human Receptor for Activated C-Kinase 1 (RACK1) Protein
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
14 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Prion-like Protein Doppel (Dpl) Interacts with the Human Receptor for Activated C-Kinase 1 (RACK1) Protein
ALBERTO AZZALIN, IGOR DEL VECCHIO, LUCA FERRETTI, SERGIO COMINCINI
Anticancer Research Nov 2006, 26 (6B) 4539-4547;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Prion-like Protein Doppel (Dpl) Interacts with the Human Receptor for Activated C-Kinase 1 (RACK1) Protein
ALBERTO AZZALIN, IGOR DEL VECCHIO, LUCA FERRETTI, SERGIO COMINCINI
Anticancer Research Nov 2006, 26 (6B) 4539-4547;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire